Time to achieve 12‐month remission (seizure‐free period) Subgroup: focal onset seizures Range of · adults and children with newly‐onset focal onset or generalised tonic‐clonic seizures
Sodium valproate showed no clear difference in time to achieve 12‐month remission (seizure‐free period) Subgroup:… compared with phenytoin monotherapy (moderate certainty).
1 finding from 1 review
Time to 12‐month remission ‐ stratified by epilepsy type ‐ generalised onset Range of · people with newly diagnosed epilepsy
Summary of findings: oxcarbazepine showed no clear difference in time to achieve 12‐month remission (seizure‐free period) Subgroup:… compared with phenytoin (secondary outcomes) (low certainty).
1 finding from 1 review
Time to treatment failure (any reason related to treatment) Subgroup: generalised onset seizures Range of · people with newly diagnosed epilepsy
Summary of findings: oxcarbazepine showed no clear difference in time to treatment failure (any reason related to treatment)… compared with phenytoin (primary outcomes) (moderate certainty).
1 finding from 1 review
Time to first seizure (post‐randomisation) Subgroup: generalised onset seizures Range of · people with newly diagnosed epilepsy
Summary of findings: oxcarbazepine showed no clear difference in time to first seizure (post‐randomisation) Subgroup: generalised… compared with phenytoin (secondary outcomes) (low certainty).
1 finding from 1 review
Mental state: General ‐ clinically important change (no improvement) · patients with schizophrenia
It is very uncertain whether COMPARISON 1: CBT+ STANDARD CARE changes mental state: General ‐ clinically important change (no improvement)… compared with STANDARD CARE ALONE (very low certainty).
1 finding from 1 review
Adverse events experienced at short or long term ‐ general adverse events 24 weeks' · patients with schizophrenia
It is very uncertain whether COMPARISON 1: CBT+ STANDARD CARE changes adverse events: General: any adverse event compared with STANDARD CARE ALONE (very low certainty).
1 finding from 1 review
Quality of life: 1. General quality of life · patients with schizophrenia
1 finding from 1 review
Mental state: General ‐ clinically important change (no improvement) · patients with schizophrenia
CBT showed no clear difference in mental state: General ‐ clinically important change (no improvement) compared with ALL OTHER PSYCHOLOGICAL THERAPIES (low certainty).
1 finding from 1 review
Generic quality of life measures · chronic rhinosinusitis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Generic HRQL (change from baseline) · chronic rhinosinusitis
2 findings from 1 review
no estimate extracted
Studies not reported
Low
no estimate extracted
Studies not reported
Low
Intervention not reported
Mental state: general ‐ average endpoint score (PANSS, high score = poor) ‐ medium term, ( · People with schizophrenia and schizophrenia‐like disorders
1 finding from 1 review
Intervention not reported
Mental state: General ‐ average endpoint score (BPRS, high score = poor) ‐ medium term ( · People with schizophrenia and schizophrenia‐like disorders
1 finding from 1 review
Intervention not reported
Functioning: general ‐ average endpoint score (GAF, high score = good) medium term ( · People with schizophrenia and schizophrenia‐like disorders
1 finding from 1 review
Intervention not reported
Quality of life: general ‐ average endpoint score (GWB, high score = good) ‐ short term ( · People with schizophrenia and schizophrenia‐like disorders
1 finding from 1 review
Expressive language: general · adults with aphasia following stroke
Summary of findings: SLT may leads to higher expressive language: general compared with no SLT (immediate outcome) (low certainty).
1 finding from 1 review
Anxiety · adults with anxiety disorders
1 finding from 1 review
Anxiety · patients with anxiety disorders
1 finding from 1 review
Anxiety · patients with anxiety disorders
1 finding from 1 review
Continuation of status requiring a different drug or general anaesthesia · patients with status epilepticus
Lorazepam IV probably leads to lower continuation of status requiring a different drug or general… compared with diazepam IV (moderate certainty).
1 finding from 1 review
Incontinence not improved (generic inverse variance) (women's observations) ‐ Systemic administration (any incontinence) · patients with urinary incontinence in post‐menopausal women
Oestrogen may leads to higher incontinence not improved (generic inverse variance) (women's… compared with placebo or no treatment (low certainty).
1 finding from 1 review